CapsoVision, Inc. Common Stock (CV) Stock Forecast & Price Target
CapsoVision, Inc. Common Stock · NASDAQ
$6.34+0.35 (+5.84%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering CapsoVision, Inc. Common Stock, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $10.00 to $10.00, so the covering firms are broadly aligned. The average target of $10.00 sits 58% above the current $6.34. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.12 next quarter toward $-0.44 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to CapsoVision, Inc. Common Stock.
As of Sep, 1 of 1 firms rate CV a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CV EPS & revenue forecast
EPS · NEXT QUARTER
$-0.12
Range $-0.12 – $-0.11 · 2 analysts · -27% YoY
Next period, 2 analysts expect CapsoVision, Inc. Common Stock to earn $-0.12 a share (range $-0.12 – $-0.11), versus $-0.16 a year earlier. Full-year consensus is $-0.56, growing to $-0.44 the year after.
REVENUE · NEXT QUARTER
$4.6M
Range $4.6M – $4.7M · 2 analysts · +10% YoY
Revenue is expected to reach $4.6M (range $4.6M – $4.7M), +10.5% year-over-year. Full-year consensus is $14.9M, rising to $19.8M next year.
Top analysts covering CapsoVision, Inc. Common Stock
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CV.
#1
Bruce Jackson
Benchmark · Rank #374
Buy
$10.00+57.7% to target
Overall win rate
36%
+ Follow
#2
KB
Kyle Bauser
Roth Capital
Buy
$11.00+73.5% to target
Coverage
—
+ Follow
CV stock forecast FAQ
What is CV's average 12-month price target?+
The 1 analysts with a live target average $10.00 for CapsoVision, Inc. Common Stock over the next 12 months, ranging from a $10.00 high to a $10.00 low.
Is CV stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover CV?+
1 analysts have an active rating on CapsoVision, Inc. Common Stock, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering CV?+
Among analysts who currently cover CV, Bruce Jackson of Benchmark has the strongest overall Quantellect track record (Rank #374). Their current call is Buy with a $10.00 target.
What is CapsoVision, Inc. Common Stock's projected EPS for next quarter?+
The consensus estimate is $-0.12 per share (range $-0.12 – $-0.11) across 2 analysts. Full-year EPS is projected at $-0.56, rising to $-0.44 the following year.
How much revenue is CapsoVision, Inc. Common Stock expected to report next quarter?+
Consensus revenue is $4.6M (range $4.6M – $4.7M). Full-year revenue is projected at $14.9M, growing to $19.8M next year.
Have analysts been upgrading or downgrading CV lately?+
As of Sep, 1 of 1 firms rate CV a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
